![McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI 1 McKesson, Merck back Atropos Health’s $33M round to accelerate drug development with AI](https://venturebeat.com/wp-content/uploads/2024/05/nuneybits_A_vector_art_image_of_a_group_of_researchers_and_heal_fb9335f1-6c0e-41b3-b511-6adff31e800f-1-transformed.webp?fit=578,324&strip=all)
Atropos Health raises $33 million in Series B funding to revolutionize healthcare with AI-powered clinical evidence generation, aiming to personalize medical decision-making and accelerate drug development. Read Full Article
Originally appeared on: TheSpuzz